Actinium Pharmaceuticals Prices Offering Of 4.4 Million Shares – Investor Newswire

Actinium Pharmaceuticals Prices Offering Of 4.4 Million Shares
Investor Newswire
Actinium Pharmaceuticals (ATNM), a biopharmaceutical company developing immunotherapeutics for the treatment of advanced cancers, has priced an underwritten public offering of an aggregate 4.4 million shares of common stock and warrants to purchase …

and more

…read more

Scroll to Top